A 43 Ca nuclear magnetic resonance perspective on octacalcium phosphate and its hybrid derivatives
© 2021 John Wiley & Sons, Ltd.
Veröffentlicht in: | Magnetic resonance in chemistry : MRC. - 1985. - 59(2021), 9-10 vom: 15. Sept., Seite 1048-1061 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2021
|
Zugriff auf das übergeordnete Werk: | Magnetic resonance in chemistry : MRC |
Schlagworte: | Journal Article 43Ca solid state NMR biomaterials hybrid organic-inorganic composites metabolic acids octa-calcium phosphate Ca8(HPO4)2(PO4)4.5H2O quadrupolar nuclei |
Zusammenfassung: | © 2021 John Wiley & Sons, Ltd. 43 Ca nuclear magnetic resonance (NMR) spectroscopy has been extensively applied to the detailed study of octacalcium phosphate (OCP), Ca8 (HPO4 )2 (PO4 )4 .5H2 O, and hybrid derivatives involving intercalated metabolic acids (viz., citrate, succinate, formate, and adipate). Such phases are of importance in the development of a better understanding of bone structure. High-resolution 43 Ca magic angle spinning (MAS) experiments, including double-rotation (DOR) 43 Ca NMR, as well as 43 Ca{1 H} rotational echo DOR (REDOR) and 31 P{43 Ca} REAPDOR NMR spectra, were recorded on a 43 Ca-labeled OCP phase at very high magnetic field (20 T), and complemented by ab initio calculations of NMR parameters using the Gauge-Including Projector Augmented Wave-density functional theory (GIPAW-DFT) method. This enabled a partial assignment of the eight inequivalent Ca2+ sites of OCP. Natural-abundance 43 Ca MAS NMR spectra were then recorded for the hybrid organic-inorganic derivatives, revealing changes in the 43 Ca lineshape. In the case of the citrate derivative, these could be interpreted on the basis of computational models of the structure. Overall, this study highlights the advantages of combining high-resolution 43 Ca NMR experiments and computational modeling for studying complex hybrid biomaterials |
---|---|
Beschreibung: | Date Completed 09.09.2021 Date Revised 09.09.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
ISSN: | 1097-458X |
DOI: | 10.1002/mrc.5149 |